Zhejiang CR Sanjiu Zhongyi Pharmaceutical Co Ltd was established in January 2006 and became a wholly owned subsidiary of China Resources Sanjiu Medical & Pharmaceutical Co Ltd in August 2015. The company is located in Zhejiang Lishui Economic and Technological Development Zone.

CR Sanjiu Zhongyi Pharmaceutical has 54 varieties of antibiotics and drugs for allergies, digestion problems, diabetes and pneumoconiosis. Its leading products are erythromycin enteric capsules, azithromycin enteric capsules and chewable magnesium tablets.

The company has four modern production lines for granules, hard capsules, tablets and active pharmaceutical ingredients with complete equipment, an advanced laboratory and an excellent quality assurance system.

At present, the annual production capacity of the company is 2 million bags of granules, 400 million capsules, 200 million tablets and 35 tons of active pharmaceutical ingredients. The company's solid preparation and active pharmaceutical ingredients workshop have passed the new version of the national GMP (Good Manufacturing Practice) certification.

Innovation is the company's primary driving force for development. CR Sanjiu Zhongyi Pharmaceutical has been continuously improving its innovative capability on new drug research and development, and has successively established a key enterprise research institute, an enterprise technology center, an academician and expert workstation, a high-tech enterprise R&D center, and a postdoctoral workstation in Zhejiang.